Under construction – not a live service
Sign in
Taking people in SwitzerlandNo phase

Tracks outcomes of patients treated for complex, calcified coronary artery disease

Observes heart patients with complex, calcified narrowed arteries who had stenting or bypass surgery.

Plain-language title generated from the registry record
Registry title: COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease

Key facts

Where
Lucerne, SwitzerlandSee the site

Where in Switzerland

  • Lucerne Heart CentreLucerne, SwitzerlandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Luzerner Kantonsspital
Trial code
NCT06075602
Record updated
29 October 2024
Original description
The purpose of the COMPLEX Registry is to prospectively and retrospectively collect baseline, clinical and procedural data of patients who have undergone PCI or CABG for complex and/ or calcified chronic CAD, irrespective of clinical presentation as well as to prospectively collect data about their clinical outcomes. The outcomes will be compared in different clinical subgroups (e.g. PCI vs. CABG). The impact of current PCI techniques/ devices, but also CABG strategies in different clinical settings and coronary artery lesions on cardiovascular outcomes will be assessed.Read full original descriptionShow less

COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease

The purpose of the COMPLEX Registry is to prospectively and retrospectively collect baseline, clinical and procedural data of patients who have undergone PCI or CABG for complex and/ or calcified chronic CAD, irrespective of clinical presentation as well as to prospectively collect data about their clinical outcomes. The outcomes will be compared in different clinical subgroups (e.g. PCI vs. CABG). The impact of current PCI techniques/ devices, but also CABG strategies in different clinical settings and coronary artery lesions on cardiovascular outcomes will be assessed.

Inclusion: Subject >18 years of age; Individuals presenting with chronic, complex and/or calcified CAD and requiring PCI or CABG; Complex coronary artery disease / lesions must include at least one of the following attributes:; Long and/ or heavily calcified coronary lesions; In-stent restenosis; Chronic total occlusions (CTO); Left main lesions; Bifurcation lesions; Bypass graft lesions; Small vessel disease / coronary microvascular dysfunction (e.g. not amenable to PCI); Subjects must be willing to sign a patient informed consent (PIC) or must have signed the General Consent (GK).

Exclusion: Patient is <18 years of age; The presence of any one of the following exclusion criteria will lead to exclusion of the patient; Patient unwilling or unable to provide informed consent; Patients with no complex and calcified CAD.

ClinicalTrials.gov NCT06075602